Align Technology | ALGN - Ordinary Share Capital


Align Technology reported $71.62M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
3M USD 516.73M 1.01M Sep/2026
Align Technology USD 71.62M 1000 Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bruker USD 152.35M 130K Jun/2026
Cardinal Health USD 233M 2M Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Cooper Companies USD 190.1M 5.01M Jun/2026
CVS Health USD 1.28B 5M Jun/2026
Danaher USD 703.4M 500K Sep/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
Henry Schein USD 111.92M 2.51M Jun/2026
Idexx Laboratories USD 78.87M 366K Jun/2026
Insulet USD 69.35M 87K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
McKesson USD 116M 4M Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Solventum Corp USD 170.11M 3.42M Jun/2026
Stryker USD 383.4M 416K Jun/2026
Teleflex USD 42.37M 1.89M Jun/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Veeva Systems USD 162.44M 756K Jun/2026
Waters USD 98.19M 20K Jun/2026
Zimmer Biomet Holdings USD 193.4M 2.1M Jun/2026
Zoetis USD 414.15M 6.19M Jun/2026